Notícias

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for coronavirus disease 2019 (COVID-19), one of the most challenging global...

Coronavirus disease 2019 is a novel disease caused by the severe acute respiratory syndrome coronavirus (SARS-CoV)-2 virus. It was first...

The efficacy and safety of tofacitinib, a Janus kinase inhibitor, in patients who are hospitalized with coronavirus disease 2019 (Covid-19)...

Safe and effective oral formulation of a drug, that is easy to store, transport, and administer, is imperative to reach...

The outbreak of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, in December 2019, and its global dissemination...

SARS-CoV-2 spike mRNA vaccines1,2,3 mediate protection from severe disease as early as ten days after prime vaccination3, when neutralizing antibodies...

The presence of antiphospholipid antibodies was shown to be associated with thrombosis in coronavirus disease 2019 (COVID-19) patients. Recently, according...

This study is an attempt to find a suitable therapy using antimicrobial peptides (AMPs) by identifying peptide-protein interaction of AMPs...

Nortec Química é a maior fabricante de Insumos Farmacêuticos Ativos (IFAs) da
América Latina e tem reconhecido papel no...

A Anvisa recebeu a solicitação de autorização temporária de uso emergencial para a
vacina contra Covid-19 da empresa Sinopharm...

Comitê de Comércio Exterior da ABIFINA aborda panorama das negociações
internacionais. Reunião avalia projeções para comércio exterior brasileiro em...

Mercado de biossimilares no Brasil. Visão profissional, de negócios e de acesso no
Fórum de Biossimilares Latam – Brasil...